Advanced search
Start date
Betweenand

Peptides with anti-tumor activity against murine melanoma (B16F10-Nex2.1) and human melanoma(A2058) based on the structure of CDRs (VH1, 2 and 3, VL1, 2 and 3) from mAb AC-1001 and mechanisms of cell death

Grant number: 10/16447-6
Support type:Scholarships in Brazil - Scientific Initiation
Effective date (Start): December 01, 2010
Effective date (End): November 30, 2012
Field of knowledge:Biological Sciences - Immunology - Cellular Immunology
Principal Investigator:Luiz Rodolpho Raja Gabaglia Travassos
Grantee:Aline Nogueira Rabaça
Home Institution: Escola Paulista de Medicina (EPM). Universidade Federal de São Paulo (UNIFESP). Campus São Paulo. São Paulo , SP, Brazil

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
RABACA, ALINE N.; ARRUDA, DENISE C.; FIGUEIREDO, CARLOS R.; MASSAOKA, MARIANA H.; FARIAS, CAMYLA F.; TADA, DAYANE B.; MAIA, VERA C.; SILVA JUNIOR, PEDRO I.; GIROLA, NATALIA; REAL, FERNANDO; MORTARA, RENATO A.; POLONELLI, LUCIANO; TRAVASSOS, LUIZ R. AC-1001 H3 CDR peptide induces apoptosis and signs of autophagy in vitro and exhibits antimetastatic activity in a syngeneic melanoma model. FEBS OPEN BIO, v. 6, n. 9, p. 885-901, SEP 2016. Web of Science Citations: 4.

Please report errors in scientific publications list by writing to: cdi@fapesp.br.